These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28794404)

  • 1. Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.
    Chen Z; Liu J; Zhang Y
    Med Sci Monit; 2017 Aug; 23():3861-3868. PubMed ID: 28794404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.
    Guo Z; Chen X; Du T; Zhu D; Lai Y; Dong W; Wu W; Lin C; Liu L; Huang H
    Med Oncol; 2017 Jan; 34(1):13. PubMed ID: 28012134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
    Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
    Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
    Xu J; Yao Q; Hou Y; Xu M; Liu S; Yang L; Zhang L; Xu H
    Biomed Pharmacother; 2013 Jun; 67(5):381-6. PubMed ID: 23601845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
    Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
    Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
    Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
    Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
    Dalla-Torre CA; Yoshimoto M; Lee CH; Joshua AM; de Toledo SR; Petrilli AS; Andrade JA; Chilton-MacNeill S; Zielenska M; Squire JA
    BMC Cancer; 2006 Oct; 6():237. PubMed ID: 17022822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
    Liu Y; Sun X; Huo C; Sun C; Zhu J
    Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
    Liu Y; Abulimiti N; Wang C
    Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 and Protein Phosphorylation Regulate the Oncogenic Role of Epithelial Cell Transforming 2 (ECT2).
    Chen Y; Tian P; Liu Y
    Med Sci Monit; 2017 Jun; 23():3154-3160. PubMed ID: 28654632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
    Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
    Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
    Sun W; Wang W; Lei J; Li H; Wu Y
    Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism.
    Qiu R; Li X; Qin K; Chen X; Wang R; Dai Y; Deng L; Ye Y
    Biofactors; 2019 Nov; 45(6):975-982. PubMed ID: 31322783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
    Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
    Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.
    Liu Z; Zhang G; Zhao C; Li J
    Med Sci Monit; 2018 Jul; 24():5216-5224. PubMed ID: 30052620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.